Paper
0
Impact of Cytogenetics, Induction Chemotherapy and MRD on Outcomes of Intensively Treated AML with KMT2A Rearrangements - Experience from UK NCRI AML17 and AML19
Authors
Jad Othman,Nicola Potter
Sylvie Freeman,Nicholas McCarthy,Jelena Jovanović,Manohursingh Runglall,Joanna Canham,Ian Thomas,Sean Johnson,Jamie Cavenagh,Panagiotis Kottaridis,David Taussig,Claire Arnold,Claire Hemmaway,Dominic Culligan,Ulrik Overgaard,Alan Burnett,Mike Dennis,Richard Dillon
+17 authors
,Nigel RussellJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave